Basilea
Basilea is a Switzerland-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of bacterial and fungal infections.
Business Model:
Revenue: $161.8M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Basilea Information
Geographic Data
Address: Grenzacherstrasse 487
City: Basel
State: basel-city
Zip: 4005
Country: CH
Financial Info
Stage:
grant
Raised Last:
$4M
Raised Total:$7M
Social
Metrics
4,606,521Website Global Rank
1,990Website Monthly Traffic
Twitter Followers
Description
Basilea is a Switzerland-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of bacterial and fungal infections.
Contact Phone:
Contact Email:
Basilea went public on 4/2/2004 on the SIX Swiss Exchange
Listed Exchange:
SIX Swiss Exchange
IPO Date:
4/2/2004
Ticker Symbol:
BSLN
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2021 | Grant | 1 | $2.7M |
CARB-X CARB-X |
8/2021 | Grant | 1 | $4.3M |
Biomedical Advanced Research and Development Authority (BARDA) Biomedical Advanced Research and Development Authority (BARDA) |
9/2022 | Post-IPO Debt | $76.4M |
Athyrium Capital Management |
5/2004 | IPO | - | 9/2022 | Post-IPO Debt | 1 | $76.8M |
Athyrium Capital Management LP Athyrium Capital Management LP |
5/2004 | IPO | - |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
